An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department (IMPROVED)
An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency Department; A Multicenter Prospective Randomized Open Trial The IMPROVED Project
Background :
Community-acquired pneumonia (CAP) is a threat in industrialized countries. It represents the 6th cause of death. CAP also frequently associates with other disorders responsible for admission and death. Among bacteria responsible for CAP, Streptococcus pneumonia is a major pathogen that is commonly involved and frequently leads to severe infection and admission. Categories at risk for this pathogen have been determined, and can be proposed anti-pneumococcal vaccination (APV) that efficiently and safely protects from this microorganism.
In the context of US health services, monocenter pilot experiences have reported improvement of pneumococcal prophylaxis implementing vaccination procedure at ED. A study that set in New Mexico (2003) reported a significant increase in APV (from 18% to 84%) when patients at risk were proposed vaccination at ED. To obtain these results, medical students were specifically trained and dedicated to screen and vaccinate against St. pneumoniae. Another single center trial (Tennessee, 2007) for APV at ED obtained an improvement (from 38.8 to 45.4%) when physicians were alerted for pneumococcal risk by the software they usually utilized at bedside. However these experiences remain sparse as additional dedicated resources are required or patients and attending ED physicians can be reluctant to proceed to vaccination at ED.
Mobile phone and derived communication modalities are current vectors to deliver information in several fields including education and medicine. Initially used in developing countries, short-message services (SMS) have improved behaviour of patients in various medical areas. In France, the investigators have observed that most patients above 50 years of age admitted after ED visit are equipped with mobile phone and can receive alerts by SMS.
These observations prompt us to propose a multifaceted procedure to improve APV after ED visit in at-risk patients, combining structured oral interview, written information and SMS as reminders.
Purpose : The investigators hypothesized that
- a multifaceted intervention to promote anti-pneumococcal vaccination combining a structured oral interview, a written information to patient and his/her general practitioner, and a series of 3 SMS,
- improves anti-pneumococcal vaccination at 6 months,
- in at-risk patients (65+ years) visiting the emergency department. In order to answer this question, the investigators designed an interventional prospective multicenter randomized study (cluster).
Descripción general del estudio
Estado
Condiciones
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Clermont-ferrand, Francia, 63003
- Centre Hospitalier Universitaire de Clermont-Ferrand
-
Issoire, Francia, 63503
- Centre Hospitalier Paul Ardier
-
Marseille, Francia, 13015
- AP-HM - Hôpital Nord
-
Marseille, Francia, 13385
- AP-HM - La Timone
-
Marseille, Francia, 13915
- Hia Laveran
-
Menton, Francia, 06507
- Centre Hospitalier La Palmosa
-
Nice, Francia, 06003
- Centre Hospitalier Universitaire De Nice
-
Orange, Francia, 84106
- Centre Hospitalier Louis Giorgi
-
Paris, Francia, 75010
- Hôpital Lariboisière
-
Paris, Francia, 75679
- Hôpital Cochin
-
Paris, Francia, 75020
- Hôpital Tenon
-
Paris, Francia, 75018
- Hôpital Bichat-Claude Bernard
-
Paris, Francia, 75013
- Hôpital Pitié-Salpêtrière
-
Saint-denis, Francia, 93200
- Centre Hospitalier de Saint-Denis
-
Vaison-la-romaine, Francia, 84110
- Centre Hospitalier de Vaison-la-Romaine
-
Valreas, Francia, 84600
- Centre Hospitalier Jules Niel
-
Vichy, Francia, 03207
- Centre Hospitalier Jacques Lacarin
-
-
-
-
-
Monaco, Mónaco, 98000
- Centre Hospitalier Princesse Grace
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- patients 65-year old and above,
- benefit from French or Monaco social security a social security.
Exclusion Criteria:
- refuse to participate,
- no possibility to receive SMS,
- impaired cognitive functions and mental status precluding understanding of the study,
- anticipated barriers precluding adequate follow-up (ex. homeless),
- previous APV,
- contraindication to APV,
- do not understand/read French.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
|---|
|
Multifaceted
|
|
Control
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Impact of a multifaceted procedure at ED visit on anti-pneumococcal vaccination. (APV) at 6-month. Evaluation criteria : Δ percentage (%) of APV vaccination at 6-month
Periodo de tiempo: 6 month
|
6 month
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
On Flu vaccination at 6-month Δ percentage (%)
Periodo de tiempo: 6 month
|
number of patients receiving vaccination against flu at 6-month.
This issue will be collected by phone (patient, relative or general practioner).
This will be a declarative data
|
6 month
|
|
On episodes of respiratory tract infections requiring antibiotics or admission at 6-month Δ (absolute number of events)
Periodo de tiempo: 6 month
|
number of patients who experienced respiratiory tract infection requiring antibiotics or admission.
This issue will be collected by phone at 6-month (patient, relative or general practioner).
This will be a declarative data
|
6 month
|
|
On death at 6- and 12-month (absolute number of events)
Periodo de tiempo: 6 month
|
6 month
|
|
|
On death related to infection at 6- and 12-month (absolute number of events)
Periodo de tiempo: 6 month
|
6 month
|
|
|
Psychosocial evaluation of patients and acceptance / refusal of vaccination
Periodo de tiempo: 6 month
|
The patient will fil a Psychosocial evaluation questionnaire during the ED visit.
To achieve this issue, we will use the socio-economic indicators mobilized in investigations in social epidemiology: sex, age, education, occupation, housing, income and household size.
This composite questionnaire will be used for qualitative analysis.
|
6 month
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Yann-Erick CLAESSENS, MD-PhD, Centre Hospitalier Princesse Grace
- Director de estudio: Xavier DUVAL, MD-PHD, Groupe Hospitalier Bichat Claude-Bernard
- Director de estudio: José LABARERE, MD, University Hospital, Grenoble
- Director de estudio: Jocelyn RAUDE, PHD, Ecole des Hautes Etudes en Santé Publique
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 12-09
- 2013-A00943-42 (Otro identificador: ANSM)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .